Taclonex Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

A statistical analysis plan for the efficiency and safety of Chinese herbal medicine used concurrently with topical therapy for psoriasis vulgaris
ConclusionsApplication of this statistical analysis plan to the YXBCM01 for PV trial will facilitate unbiased evaluation of these important clinical data. This study will provide evidence regarding the value of YXBCM01 as an intervention for PV patients.Trial registrationChinese Clinical Trial Registry:ChiCTR-TRC-13003233, registered on 26 May 2013. (Source: Trials)
Source: Trials - October 2, 2016 Category: Research Source Type: clinical trials

Study of the Efficacy of Early Intervention With Secukinumab 300 mg s.c. Compared to Narrow-band UVB in Patients With New-onset Moderate to Severe Plaque Psoriasis
Condition:   Plaque Psoriasis Interventions:   Biological: Secukinumab;   Radiation: nbUVB;   Biological: Secukinumab;   Biological: Secukinumab;   Biological: Secukinumab;   Drug: Calcipotriol;   Drug: Betamethasone Sponsor:   Novartis Pharmaceuticals Not yet recruiting - verified January 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 23, 2016 Category: Research Source Type: clinical trials